VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -9.60M | -11.38M | -17.30M | -19.60M | -20.98M |
| Total Depreciation and Amortization | 74.90K | 99.20K | 119.30K | 133.40K | 136.40K |
| Total Amortization of Deferred Charges | 1.56M | 1.62M | 6.01M | 6.86M | 6.94M |
| Total Other Non-Cash Items | 895.80K | 1.23M | 1.36M | 1.43M | 1.27M |
| Change in Net Operating Assets | 965.90K | 1.12M | 1.22M | 79.60K | 764.00K |
| Cash from Operations | -6.11M | -7.31M | -8.60M | -11.10M | -11.86M |
| Capital Expenditure | -- | 0.00 | -8.90K | -13.40K | -16.20K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 500.00 | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | -8.90K | -12.90K | -15.70K |
| Total Debt Issued | 4.00M | 3.00M | 5.85M | 9.25M | 10.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.30K | 1.30K | 1.30K | 300.00 | 2.00K |
| Repurchase of Common Stock | -800.00 | -800.00 | -800.00 | -800.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.00M | 3.00M | 5.85M | 9.25M | 10.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.11M | -4.31M | -2.76M | -1.86M | -1.87M |